The Riverside Company (Riverside), a global investment firm focused on the smaller end of the middle market, has announced that Decera Clinical, a healthcare portfolio company, has invested in Onviv, Inc. Founded in 2015, Onviv’s specialized lines of business include real-world intelligence, scientific communications, training expertise and stakeholder engagement that support informed decisions and drive meaningful outcomes for clients and patients. This investment expands Decera Clinical’s capabilities across healthcare insights, scientific engagement and medical communications, combining complementary expertise, proprietary methodologies and longstanding industry relationships.
Read the full article: The Riverside Company’s Decera Clinical Invests in Onviv, Further Strengthening Its Position as a Leading Scientific Activation Partner to the Life Sciences Industry //
Source: https://www.riversidecompany.com/currents/the-riverside-companys-decera-clinical-invests-in-onviv